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Background: The effects of proton-pump inhibitors (PPI) on mortality in stable ischemic heart disease (SIHD) patients (pts) with or without 
diabetes mellitus (DM) treated with optimal medical therapy (OMT) who undergo elective percutaneous intervention (PCI) have not been well 
studied.
methods: Long-term (70±1 months) mortality was ascertained in 329 consecutive pts undergoing elective PCI (mean age: 63±12 years, females: 
31%, hypertension: 73%, DM: 26%, current smoking: 22%, PPI therapy: 21%) on OMT, including: beta-blockers (96%), ACEI/ARB (72%), aspirin ± 
clopidogrel (97%), and statin (76%) at the time of PCI. Platelet function (PFA-100) testing was performed (normal range of 80-184 sec).
results: Treatment with PPIs had no significant effect on platelet inhibition (PFA 259±63 vs. 240±79 sec in the non-PPI group, P=0.06). There was 
a numerical trend towards reduced post-PCI bleeding complications with PPI therapy (1.4% vs. 2.7% in the non-PPI group, P=0.55). In multivariate 
analyses, DM (HR 2.6, 95%CI 1.3-5.3, P=0.007) and older age (HR 2.2 per decade, 95%CI 1.5-3, P<0.001) were associated with increased mortality. 
Mortality was significantly improved in pts with DM on PPI therapy (10% in −DM/−PPI, 17% in −DM/+PPI and +DM/−PPI, vs. 28% in +DM/−PPI, 
chi-square P=0.008, log-rank P=0.0025, Figure).
conclusions: In SIHD pts on OMT undergoing elective PCI, PPIs do not appear to have a significant effect on platelet inhibition. However, PPI 
therapy may be associated with improved survival in DM pts.
 
